Always private
DuckDuckGo never tracks your searches.
Learn More
You can hide this reminder in Search Settings
All regions
Argentina
Australia
Austria
Belgium (fr)
Belgium (nl)
Brazil
Bulgaria
Canada (en)
Canada (fr)
Catalonia
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India (en)
Indonesia (en)
Ireland
Israel (en)
Italy
Japan
Korea
Latvia
Lithuania
Malaysia (en)
Mexico
Netherlands
New Zealand
Norway
Pakistan (en)
Peru
Philippines (en)
Poland
Portugal
Romania
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain (ca)
Spain (es)
Sweden
Switzerland (de)
Switzerland (fr)
Taiwan
Thailand (en)
Turkey
Ukraine
United Kingdom
US (English)
US (Spanish)
Vietnam (en)
Safe search: moderate
Strict
Moderate
Off
Any time
Any time
Past day
Past week
Past month
Past year
  1. sciencedirect.com

    The Iboga plant Tabernanthe iboga (Apocynaceæ) was first classified 140 years ago, although descriptions of it and samples of it were exhibited in France in the 1860s (Goutarel et al., 1993).In 1905 it was reported that the plant was ascribed stimulatory and even aphrodisiac properties. Its consumption held off fatigue, the need to sleep and provided energy to work.
    Author:John Martin CorkeryPublished:2018
  2. pmc.ncbi.nlm.nih.gov

    Ibogaine was initially marketed in France in the 1930s as a medical product called Lamberene and was used to treat depression, fatigue, and infectious diseases (Goutarel et al., 1993). In the early 1960s, Howard Lotsof identified ibogaine as effective in ameliorating withdrawal and craving from his own heroin addiction ( Alper, Beal, & Kaplan ...
  3. ncbi.nlm.nih.gov

    National Center for Biotechnology Information

    https://www.ncbi.nlm.nih.gov › pmc › articles › PMC8490685

    Ibogaine is a psychedelic extracted from the plant Tabernanthe iboga Baill.(Apocynaceae), natural from Africa, and has been proposed as a potential treatment for substance use disorders.In animal models, ibogaine reduces ethanol self-administration. However, no study to date has investigated the effects of ibogaine on ethanol-induced conditioned place preference (CPP).
    Publication:Front Pharmacol. 2021; 12: 739012.Author:Gabrielle M. Henriques, Alexia Anjos-Santos, Isa R. S. Rodrigues, Victor Nascimento-Rocha, Henrique ...Published:2021
  4. journals.sagepub.com

    9 Goutarel R Gollnhofer O Sillans R . Pharmacodynamics and therapeutic applications of Iboga and Ibogaine. Psychedelic Monogr Essays 1993; 6: 71-111. Google Scholar ... J Liquid Chromatogr Analyt Technol Biomed Life Sci 2007; 30: 1077-1092. Google Scholar. 25 Taylor WI . The iboga and Vocanca alkaloids. The alkaloids, Chemistry and Physiology.
    Author:R Maciulaitis, V Kontrimaviciute, F M M Bressolle, V BriedisPublished:2008
  5. pmc.ncbi.nlm.nih.gov

    Goutarel R, Gollnhofer O, and Sillans R (1993). Pharmacodynamics and therapeutic applications of iboga and ibogaine. Psychedelic Monographs and Essays 66: 71-111. ... Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice. Sci. Rep 8(1): 613.
  6. ibogainedossier.com

    Therapeutic applications . The first step in the pharmacodynamic studies began when Phisalix (1901) 43 showed that, in the dog, this alkaloid acts principally on the CNS and produces inebriation similar to alcoholic drunkenness (though this would be contradicted later). This was the period of studies by the French pharmacologists, Lambert, (1901) 30, (1902) 31 Heckel, (1901) 28 and Pouchet ...
  7. Can’t find what you’re looking for?

    Help us improve DuckDuckGo searches with your feedback

Custom date rangeX